HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases.

Abstract
Defects in apoptosis are frequently the cause of cancer emergence, as well as cellular resistance to chemotherapy. These phenotypes may be due to mutations of the tumor suppressor TP53 gene. In this study, we examined the effect of various mitotic spindle poisons, including the new isocombretastatin derivative isoNH2CA-4 (a tubulin-destabilizing molecule, considered to bind to the colchicine site by analogy with combretastatin A-4), on BL (Burkitt lymphoma) cells. We found that resistance to spindle poison-induced apoptosis could be reverted in tumor protein p53 (TP53)-mutated cells by EBV (Epstein Barr virus) infection. This reversion was due to restoration of the intrinsic apoptotic pathway, as assessed by relocation of the pro-apoptotic molecule Bax to mitochondria, loss of mitochondrial integrity and activation of the caspase cascade with PARP (poly ADP ribose polymerase) cleavage. EBV sensitized TP53-mutated BL cells to all spindle poisons tested, including vincristine and taxol, an effect that was systematically downmodulated by pretreatment of cells with inhibitors of p38 and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases. Exogenous activation of p38 and JNK pathways by dihydrosphingosine reverted resistance of TP53-mutated BL cells to spindle poisons. Dihydrosphingosine treatment of TP53-deficient Jurkat and K562 cell lines was also able to induce cell death. We conclude that activation of p38 and JNK pathways may revert resistance of TP53-mutated cells to spindle poisons. This opens new perspectives for developing alternative therapeutic strategies when the TP53 gene is inactivated.
AuthorsM Farhat, A Poissonnier, A Hamze, C Ouk-Martin, J-D Brion, M Alami, J Feuillard, C Jayat-Vignoles
JournalCell death & disease (Cell Death Dis) Vol. 5 Pg. e1201 (May 01 2014) ISSN: 2041-4889 [Electronic] England
PMID24787013 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Protein Kinase Inhibitors
  • Tumor Suppressor Protein p53
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Sphingosine
  • safingol
Topics
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Apoptosis (drug effects)
  • B-Lymphocytes (drug effects, pathology)
  • Burkitt Lymphoma (enzymology, pathology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Drug Resistance, Neoplasm (drug effects)
  • Enzyme Activation (drug effects)
  • Herpesvirus 4, Human (physiology)
  • Humans
  • Inhibitory Concentration 50
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Mitochondria (drug effects, metabolism)
  • Mutation (genetics)
  • Protein Kinase Inhibitors (pharmacology)
  • Signal Transduction (drug effects)
  • Sphingosine (analogs & derivatives, pharmacology)
  • Spindle Apparatus (drug effects)
  • Tumor Suppressor Protein p53 (genetics)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: